Celularity Inc. (CELU)
NASDAQ: CELU · IEX Real-Time Price · USD
3.105
-0.085 (-2.66%)
At close: Jul 2, 2024, 4:00 PM
3.100
-0.005 (-0.16%)
After-hours: Jul 2, 2024, 4:20 PM EDT

Celularity Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2022202120202019
Market Capitalization
68187632395358
Market Cap Growth
-87.11%-70.41%59.91%10.55%-
Enterprise Value
112221609351342
PE Ratio
-13.18-6.31-1.90-1.69
PS Ratio
4.5710.4129.6327.6916.91
PB Ratio
2.240.946.36-0.74-1.09
P/FCF Ratio
-0.65-1.31-5.44-4.34-3.64
P/OCF Ratio
-0.66-1.36-5.74-6.26-5.35
EV/Sales Ratio
7.5412.3128.5324.5916.18
EV/EBITDA Ratio
-0.519.39-6.91-1.73-1.31
EV/EBIT Ratio
-0.4815.58-6.28-1.67-1.28
EV/FCF Ratio
-1.32-1.55-5.23-3.86-3.48
Debt / Equity Ratio
2.020.330.31-0.06-0.09
Debt / EBITDA Ratio
-0.362.78-0.35-0.15-0.11
Debt / FCF Ratio
-0.94-0.46-0.27-0.34-0.29
Quick Ratio
0.250.582.192.852.26
Current Ratio
0.200.542.252.711.78
Asset Turnover
0.050.040.050.040.08
Interest Coverage
-76.12--30.57-89.46-
Return on Equity (ROE)
-144.20%9.40%37.60%161.30%267.00%
Return on Assets (ROA)
-62.20%3.30%-24.20%-63.70%-76.90%
Return on Capital (ROIC)
-378.09%-57.37%-115.05%41.44%65.23%
Earnings Yield
-268.21%7.59%-15.84%-52.68%-59.25%
FCF Yield
-96.36%-76.50%-18.40%-23.03%-27.48%
Buyback Yield / Dilution
-25.09%-123.44%-264.09%22.85%-
Total Shareholder Return
-25.09%-123.44%-264.09%22.85%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).